Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Evidence For Cannabidiol Modulation of Serotonergic Transmission in a Model of Osteoarthritis via <i>in vivo</i> PET Imaging and Behavioral Assessment.

International journal of innovative research in medical science·2023
Same author

RS12574989 and haplotype associated with α/β-chain imbalance and population HbA2 reduction.

BMC medical genomics·2022
Same author

Cooperative ETM-Based Adaptive Neural Network Tracking Control for Nonlinear Pure-Feedback MASs: A Special-Shaped Laplacian Matrix Method.

IEEE transactions on neural networks and learning systems·2022
Same author

Effect of femoral head necrosis cystic area on femoral head collapse and stress distribution in femoral head: A clinical and finite element study.

Open medicine (Warsaw, Poland)·2022
Same author

Novel optimal trajectory tracking for nonlinear affine systems with an advanced critic learning structure.

Neural networks : the official journal of the International Neural Network Society·2022

相关实验视频

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

药物开发 药物开发

Fernando Goni1, Ding Wang1, Jianina Suazo1

  • 1NYU Grossman School of Medicine, New York, NY, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括

一种新的类和类组合疗法有效地减少了粉样β (Aβ) 病理,并改善了阿尔茨海默氏症患者的认知能力.

更多相关视频

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

相关实验视频

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

科学领域:

  • 神经科学是一个神经科学.
  • 药理学 药理学是指药理学的学科.
  • 遗传学 是一个遗传学.

背景情况:

  • 之前的研究表明,一种类蛋白 (LPFFA) 减少了粉样β (Aβ) 病理,并通过防止Aβ与阿波利波蛋白E (apoE) 结合,在阿尔茨海默病 (AD) 鼠标模型中改善认知.
  • 新的已被开发来破坏对apoE构造和病理功能至关重要的α-螺旋体.
  • 这项研究调查了使用类和两种新 (127和148) 的组合疗法的疗效和安全性,用于表达人类apoE异型 (E2,E3,E4) 的脑粉样血管病变 (CAA) 的转基因小鼠模型.

研究的目的:

  • 评估一种结合治疗的治疗效果,包括一个类和两个特定的类,以减少Aβ病理和改善认知功能.
  • 在AD小鼠模型中评估这种组合治疗的安全性,特别是关于微型出血和质激活,在不同的人类apoE背景下.
  • 为了确定治疗的有效性是否取决于转基因模型中表达的特定的人类apoE异型 (E2,E3或E4).

主要方法:

  • 在临床前试验中使用了表达人类apoE2,apoE3或apoE4的转基因 SwDI小鼠模型.
  • 动物每周接受三个月的-组合 (100微克/动物/化合物) 或载体的腹膜内注射.
  • 治疗后的评估包括运动和认知测试 (巴恩斯迷宫),随后是脑组织的免疫组织化学和生物化学分析.

主要成果:

  • 结合疗法显著改善了所有apoE背景的认知功能,与对照组相比,根据巴恩斯迷宫的测量.
  • 观察到血管和辅酶Aβ病理的显著减少,而小出血或质激活的增加没有 (Iba1,GFAP,CD-45).
  • 表达人类apoE4的Tg小鼠表现出最大的行为改善,尽管认知结果与apoE3 KI动物相似.

结论:

  • 减少Aβ与apoE结合并破坏其病态构造,有效地减少了AD小鼠模型中的Aβ病理.
  • 组合疗法是安全和新的,没有像ARIA (粉样蛋白相关的成像异常) 这样的不良影响.
  • 这种方法在阿尔茨海默氏病模型中提供了一种有希望的策略,可以防止Aβ病理的早期沉积和进展.